Plant-made pharmaceuticals and their impact on food security: Gap analysis of the current regulations

Authors

  • Rosane Cuber Guimarães Instituto de Tecnologia em munológicos, Fundação Oswaldo Cruz (Bio-Manguinhos / Fiocruz), Rio de Janeiro, RJ Author
  • Marcos da Silva Freire Instituto de Tecnologia em munológicos, Fundação Oswaldo Cruz (Bio-Manguinhos / Fiocruz), Rio de Janeiro, RJ Author
  • Antonio Eugenio Castro Cardoso de Almeida Instituto Nacional de Controle de Qualidade em Saúde, Fundação Oswaldo Cruz (INCQS / Fiocruz), Rio de Janeiro, RJ Author

DOI:

https://doi.org/10.3395/vd.v2n4.399

Keywords:

Genetically Modified Plants, Plant-made Pharmaceuticals, Food Security, Regulation, Gap Analysis

Abstract

The use of genetically modified plants to synthesize proteins that are subsequently processed, regulated, and sold as pharmaceuticals is already a global reality. However, the issue of technological development and industrial production of biological products being expressed in transgenic plants and their impact on the safety of the food chain needs to be discussed more deeply. In this paper, we present an extensive literature review on the standards and regulatory guidelines as well as on biosafety in Brazil with regard to the production of plant-made pharmaceuticals; compare them with the regulatory guidelines of other countries/regions such as USA, Canada, European Union, Cuba, and Argentina; and analyze gaps in the Brazilian regulation. . We suggest that some regulations must be reviewed and conclude that the Brazilian regulatory authorities should establish an interrelated regulatory framework together, which would enable industrial production while protecting human and animal health as well as the environment.

Downloads

Download data is not yet available.

Author Biographies

  • Rosane Cuber Guimarães, Instituto de Tecnologia em munológicos, Fundação Oswaldo Cruz (Bio-Manguinhos / Fiocruz), Rio de Janeiro, RJ

    Doutoranda do Programa de Pós-Graduação em Vigilância Sanitária - INCQS / Fiocruz

    Tecnologista em Saúde Pública lotada em Bio-Manguinhos - Fiocruz no Laboratório de Tecnologia Virológica.

  • Marcos da Silva Freire, Instituto de Tecnologia em munológicos, Fundação Oswaldo Cruz (Bio-Manguinhos / Fiocruz), Rio de Janeiro, RJ

    Doutor em Virologia pelo IOC - Fiocruz

    Vice-Diretor de Desenvolvimento Tecnológico de Bio-Manguinhos

  • Antonio Eugenio Castro Cardoso de Almeida, Instituto Nacional de Controle de Qualidade em Saúde, Fundação Oswaldo Cruz (INCQS / Fiocruz), Rio de Janeiro, RJ

    Doutor em Vigilância Sanitária pelo INCQS / Fiocruz

    Professor do Programa de Pós-Graduação em Vigilância Sanitária INCQS - Fiocruz

    Departamento de Microbiologia

    Chefe do Setor de Vacina Hib

Published

2014-11-27

How to Cite

Plant-made pharmaceuticals and their impact on food security: Gap analysis of the current regulations. (2014). Health Surveillance under Debate: Society, Science & Technology , 2(4), 76-85. https://doi.org/10.3395/vd.v2n4.399